- Filed
- Feb 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Jan 31, 2025 | 55.89M sh |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $3.71B |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | $3.12B |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $4.12B |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $3.21B |
| Current Assets | Q2 2025 · Dec 31, 2024 | $4.24B |
| Current Assets | Q2 2025 · Jun 30, 2024 | $3.52B |
| Total Assets | Q2 2025 · Dec 31, 2024 | $5.29B |
| Total Assets | Q2 2025 · Jun 30, 2024 | $4.25B |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $401.81M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2023 | $366.9M |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 56.86M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 56.91M sh |
| Stock Repurchased | Q2 2025 · Dec 31, 2023 | $0 |
| Capex | Q2 2025 · Dec 31, 2023 | $6.14M |
| Operating Cash Flow | Q2 2025 · Dec 31, 2023 | $137.21M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $986.77M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $892.64M |
| Stockholders Equity | Q2 2025 · Jun 30, 2023 | $842.86M |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | $0.67 |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | $1.28 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | $0.68 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | $1.29 |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $43.34M |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $93.26M |
| Rd Expense | Q2 2025 · Dec 31, 2023 | $46.14M |
| Rd Expense | Q2 2025 · Dec 31, 2023 | $90.74M |
| Net Income | Q2 2025 · Dec 31, 2023 | $38.12M |
| Net Income | Q2 2025 · Dec 31, 2023 | $72.63M |
| Operating Income | Q2 2025 · Dec 31, 2023 | $49.71M |
| Operating Income | Q2 2025 · Dec 31, 2023 | $90.9M |
| Gross Profit | Q2 2025 · Dec 31, 2023 | $218.96M |
| Gross Profit | Q2 2025 · Dec 31, 2023 | $435.08M |
| Revenue | Q2 2025 · Dec 31, 2023 | $298.42M |
| Revenue | Q2 2025 · Dec 31, 2023 | $590.1M |